Others

Glenmark Pharmaceuticals Ltd. - Closure of Trading Window

| Updated on July 30, 2018 Published on July 30, 2018

We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Friday, August 10, 2018, inter alia, to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2018.

Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from July 1, 2018 to August 12, 2018 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the First Quarter ended June 30, 2018.

Pdf Link: Glenmark Pharmaceuticals Ltd. - Closure of Trading Window

Source : BSE - www.bseindia.com

Published on July 30, 2018
This article is closed for comments.
Please Email the Editor